scispace - formally typeset
L

Lars Dahlström

Researcher at University of Gothenburg

Publications -  31
Citations -  916

Lars Dahlström is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Orofacial pain & Masseter muscle. The author has an hindex of 16, co-authored 31 publications receiving 835 citations. Previous affiliations of Lars Dahlström include Sahlgrenska University Hospital.

Papers
More filters
Journal ArticleDOI

Temporomandibular disorders and oral health-related quality of life. A systematic review.

TL;DR: The reviewed studies convincingly demonstrated that OHRQoL was negatively affected among TMD patients.
Journal ArticleDOI

Cognitive-behavioral profiles among different categories of orofacial pain patients: diagnostic and treatment implications

TL;DR: It was concluded that the robustness of the MPI as a relevant assessment instrument was further strengthened and some support for a cyclical causality between pain and psychological factors was found.
Journal ArticleDOI

Comparison of effects of electromyographic biofeedback and occlusal splint therapy on mandibular dysfunction.

TL;DR: The two treatments, biofeedback and occlusal splint therapy, were equally effective in the short-term perspective in patients with signs and symptoms of mandibular dysfunction.
Journal ArticleDOI

Stress-induced muscular activity in mandibular dysfunction: effects of biofeedback training.

TL;DR: Biofeedback treatment for the patients resulted in significantly reduced signs and symptoms of mandibular dysfunction and integrated electromyographic activity was not significantly different for the two sides but was higher for patients than for controls during both stress and relaxation.
Journal ArticleDOI

Bite plates and stabilization splints in mandibular dysfunction. A clinical and electromyographic comparison.

TL;DR: Twenty patients with mandibular dysfunction, all women, aged 17-41 years, were randomized for treatment with either a bite plate with a frontal plateau or a full-coverage stabilization splint, and the clinical signs and subjective symptoms improved in both groups.